Results 151 to 160 of about 76,145 (237)

Efficacy of Parenteral Cefotaxime Versus Combination of Piperacillin & Tazobactam as Empiric First Line Therapy in the Treatment of Spontaneous Bacterial Peritonitis

Journal of Society of Surgeons of Nepal
Introduction: Cefotaxime is the empiric antibiotic of choice for spontaneous bacterial peritonitis (SBP). However, rising gram-positive pathogen rates have prompted consideration of piperacillin-tazobactam as an alternative.
Ajit Khanal, Anil Kumar Mishra
doaj  

Correlation of OXA-1 and TEM-1 genes with antibiotic resistance to piperacillin/tazobactam in ESBL-producing Enterobacterales: insights from a multi-center analysis. [PDF]

Front Cell Infect Microbiol
Kamau E, Wong BM, MacArthur JL, Dombach JL.   +3 more
europepmc   +1 more source

UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland. [PDF]

JAC Antimicrob Resist
Goswami C, Turgal E, Mueller T, Bennie M, Parr R, Jones GT, Seaton RA, Jenkins D, Baltas I, Sneddon J, Sandoe JAT, Garraghan F, Brown NM, Macfarlane GJ, Kurdi A.   +14 more
europepmc   +1 more source

A Large Community-Acquired Lung Abscess Caused by Pseudomonas aeruginosa: Diagnostic and Therapeutic Challenges. [PDF]

Cureus
Al Hariri B, Thaher R, Osman Z, Zada Y, Sheikh Al Ard Khanji A.   +4 more
europepmc   +1 more source

Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology. [PDF]

J Pediatr Pharmacol Ther
Angelini J, Russiani F, Ferin S, Flammini S, Tascini C, Roberts JA, Baraldo M, Giuliano S.   +7 more
europepmc   +1 more source

Effects of a high proportion of cefoperazone/tazobactam on lung function and bacterial clearance rate in patients with chronic obstructive pulmonary disease and lower respiratory tract infection Klebsiella pneumoniae. [PDF]

Eur J Med Res
Wu Q, Xu N, Liu L, Ye F, Li C.
europepmc   +1 more source

Comparative analysis of the effects of aztreonam combined with four β-lactamase inhibitors against carbapenem-resistant <i>Enterobacterales</i>. [PDF]

Microbiol Spectr
Meng Q, Xu C, Li W, Shen K, Huang X, Fu X, Zhou L, Chen Y, Hu F, Wang H.   +9 more
europepmc   +1 more source

<i>Delftia</i> spp as Opportunistic Pathogens: a narrative review. [PDF]

New Microbes New Infect
Ryan MP, Tony Pembroke J.
europepmc   +1 more source

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database. [PDF]

Pharmaceuticals (Basel)
Arseniu AM, Vintila BI, Butuca A, Stoicescu L, Frum A, Chis AA, Arseniu R, Gligor FG, Ghibu S, Morgovan C, Dobrea CM.   +10 more
europepmc   +1 more source

The use of thrombolytics in the management of complex pleural fluid collections [PDF]

, 2017
Bahjri, Khaled, Copeland, Hannah, Duldulao, Marjulin, Heimes, Jessica, Lulla, Aditya, Wallen, Jason M, Zaheer, Salman   +6 more
core   +2 more sources